(Q67777162)
Statements
Treatment of myelodysplastic syndromes with orally administered 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate (English)
Treatment of Myelodysplastic Syndromes with Orally Administered l-β-Z)-Arabinofuranosylcytosine-5’-Stearylphosphate (English)
1 reference
1 reference
R. Ohno
N. Tatsumi
M. Hirano
K. Imai
H. Mizoguchi
T. Nakamura
M. Kosaka
K. Takatsuki
T. Yamaya
1 January 1991